
Archived App (Last seen on 12 May 2026)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
Access a vast library of US payer reimbursement policies for specialty drugs, focusing on autoimmune and oncology treatments. Quickly find medical policies and prior authorization forms, track coverage trends, and generate custom drug reports.
What's New in PolicyView
3.2.0
February 25, 2025
The app has been updated for the latest iOS version
Developer apps
FAQ
What is PolicyView?
PolicyView is a free app for iPad and iPhone that provides access to a comprehensive library of US payer reimbursement policies for specialty drugs, particularly for autoimmune and oncology treatments.
What types of drugs does PolicyView cover?
PolicyView focuses on specialty drugs for Autoimmune conditions such as Rheumatoid Arthritis, Psoriasis, Multiple Sclerosis, Crohn’s/Ulcerative Colitis, and Lupus, as well as Oncology drugs for various cancers.
Can I find prior authorization forms with PolicyView?
Yes, PolicyView provides direct access to thousands of Medical Policies and Prior Authorization Forms for Autoimmune and Oncology therapeutic agents.
How does PolicyView help track coverage trends?
PolicyView allows users to track trends in payer coverage policies by category over time, providing insights into changes in reimbursement criteria.
Is PolicyView available on Android devices?
PolicyView is currently compatible with iPad and iPhone devices only.
How often are the policies in PolicyView updated?
Pharmspective's ongoing surveillance of payer policies ensures subscribers have access to the most recent reimbursement criteria, representing the majority of total insured lives in the U.S.
Does PolicyView have ads?
No, PolicyView is ad-free, allowing for an uninterrupted user experience.
What is the age rating for PolicyView?
PolicyView has an age rating of 4+, making it suitable for a wide range of users.






